Urine Detection of EGFR T790M Mutation in Non-Small-Cell Lung Cancer: An Outcomes and Total Cost of Care Analysis

被引：1
|
作者：
Sands, Jacob [1 ]
Hornberger, John [2 ]
机构：
[1] Lahey Hosp & Med Ctr, Oncol, Burlington, MA USA
[2] Cedar Associates Llc, Menlo Pk, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; T790M; liquid biopsy; Health Economics;
D O I：
10.1016/j.jtho.2016.11.1677
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b010
引用
收藏
页码：S1191 / S1191
页数：1
相关论文
共 50 条
  • [1] Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis
    Sands, Jacob
    Li, Qianyi
    Hornberger, John
    LUNG CANCER, 2017, 110 : 19 - 25
  • [2] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [3] Detection of EGFR T790M mutation in non-small-cell lung cancer patients using colony hybridization assay
    Fujita, Yoshihiko
    Suda, Kenichi
    Kimura, Hideharu
    Matsumoto, Kazuko
    Arao, Tokuzo
    Nagai, Tomoyuki
    Hayashi, Hidetoshi
    Furuta, Kazuyuki
    Kato, Hiroaki
    Saijo, Nagahiro
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [4] Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
    Kim, Insu
    Seol, Hee Yun
    Kim, Soo Han
    Kim, Mi-Hyun
    Lee, Min Ki
    Eom, Jung Seop
    CANCERS, 2023, 15 (05)
  • [5] The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancer
    Gao, Xin
    Le, Xiuning
    Costa, Daniel B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 383 - 390
  • [6] Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer
    Kawamura, Takahisa
    Kenmotsu, Hirotsugu
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Omae, Katsuhiro
    Mori, Keita
    Tanigawara, Yusuke
    Nakajima, Takashi
    Ohde, Yasuhisa
    Endo, Masahiro
    Takahashi, Toshiaki
    CLINICAL LUNG CANCER, 2018, 19 (02) : E247 - E252
  • [7] Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
    Yamane, Hiromichi
    Ochi, Nobuaki
    Yasugi, Masayuki
    Tabayashi, Takayuki
    Yamagishi, Tomoko
    Monobe, Yasumasa
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Takigawa, Nagio
    ONCOTARGETS AND THERAPY, 2013, 6 : 155 - 160
  • [8] Therapeutic approaches for T790M mutation positive non-small-cell lung cancer
    Attili, Ilaria
    Karachaliou, Niki
    Conte, PierFranco
    Bonanno, Laura
    Rosell, Rafael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 1021 - 1030
  • [9] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
    Prim, Nathalie
    Quoix, Elisabeth
    Beau-Faller, Michele
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
  • [10] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
    Jenkins, Suzanne
    Yang, James C-H.
    Ramalingam, Suresh S.
    Yu, Karen
    Patel, Sabina
    Weston, Susie
    Hodge, Rachel
    Cantarini, Mireille
    Janne, Pasi A.
    Mitsudomi, Tetsuya
    Goss, Glenwood D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
12345